✦ LIBER ✦

A phase I study of irinotecan (I), gemcitabine (G), and 5-fluorouracil (5-FU) in patients with advanced gastrointestinal cancers

✍ Scribed by Schlottmann, K.; Friedrich, A.; Messmann, H.; Stoffregen, C.; Scholmerich, J.; Kullmann, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine (GEM) and 5-fluorouracil (5

✍ Cascinu, S.; Frontini, L.; Labianca, R.; Silva, R.; Ferretti, B.; Bami, S.; Cata 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Phase I study of gefitinib, irinotecan,

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

Weekly gemcitabine (GEM) and 5-fluoroura

✍ P. Tarantini; D.C. Corsi; A. Cassano; C. Pozzo; L. Angelelli; C. Signorelli; M. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A phase I, dose-finding study of irinote

✍ Javier Sastre; Luis Paz-Ares; Antonio Carcas; Rosario Alfonso; Cristina Grávalos 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 299 KB

A phase I–II study of concomitant 5-fluo

✍ G. Arcangeli; G.C. Arcangeli; F. Angelini; R. Tersigni; T. Scala; C. Ambrogi 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 136 KB

A phase I study of paclitaxel and 5-fluo

✍ S. Cascinu; R. Ficarelli; M.A.A. Safi; F. Graziano; G. Catalano; R. Cellerino 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 380 KB